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Introduction {#sec005}
============

Low-Back Pain (LBP) is a major public health challenge with a high disability burden \[[@pone.0221138.ref001]\]. According to the 2010 Global Burden of Disease Study, LBP is among the top 10 diseases and injuries that account for the highest number of disability-adjusted life-years worldwide \[[@pone.0221138.ref002]\]. As a result of this, outcome tools that assess the disability resulting from LBP have become more abundant. Among the outcome tools, Roland-Morris Disability Questionnaire and Oswestry Disability Index (ODI) \[[@pone.0221138.ref003]--[@pone.0221138.ref005]\] are mostly recommended \[[@pone.0221138.ref006]\] owing to abundant reports literature on their clinimetric and psychometric properties \[[@pone.0221138.ref003],[@pone.0221138.ref005],[@pone.0221138.ref007],[@pone.0221138.ref008]\].

Researchers and clinicians often use the Oswestry Disability Index (ODI) as a disease-specific questionnaire to assess pain and disability resulting from LBP \[[@pone.0221138.ref003],[@pone.0221138.ref005],[@pone.0221138.ref007]\]. Fairbank et al. developed the ODI as a self-administered 10-item questionnaire \[[@pone.0221138.ref008]\]. The ODI assesses the consequences of pain on typical daily activities, including personal care, lifting, walking, sitting, standing, sleeping, sex life, social life, and travelling \[[@pone.0221138.ref008]\]. The anchors of the tool vary from no disability (0) to maximum disability (100) \[[@pone.0221138.ref008]\]. Based on psychometric properties and clinical usability, various languages translations including the Greek \[[@pone.0221138.ref009]\], Norwegian \[[@pone.0221138.ref010]\], Japanese \[[@pone.0221138.ref011]\], Turkish \[[@pone.0221138.ref012]\], Korean \[[@pone.0221138.ref013]\], Arabic \[[@pone.0221138.ref014]\], German \[[@pone.0221138.ref015]\], Danish \[[@pone.0221138.ref016]\], Iranian \[[@pone.0221138.ref017]\], Brazilian-Portuguese \[[@pone.0221138.ref018]\], Italian \[[@pone.0221138.ref019]\] and Tamil \[[@pone.0221138.ref020]\] exist. Most of these translations report excellent psychometric properties. The ODI has a Cronbach *α* ranging from 0.71 to 0.87, an intra-class correlation coefficient from 0.84 to 0.94 and a test-retest reliability value between 0.83 and 0.99 \[[@pone.0221138.ref007]\].

As cultural groups vary in disease perception and expressions and their use of various health care systems, local languages enhance the comprehensibility of outcome tools. \[[@pone.0221138.ref021]\]. Thus, increasing the comprehensibility and usability of outcome tools, especially among non-English speakers necessitated the translation of outcome tools or questionnaires into local languages. Further, patients find outcomes translated into their local languages as easily accessible, user-friendly, and comprehensible \[[@pone.0221138.ref022]\]. To date, only one translation (Hausa version) of the ODI with requisite data on validity and reliability exist \[[@pone.0221138.ref023]\], thus the need for translations of the ODI in other Nigeria languages.

Although English is the official language in Nigeria, a sizeable number of Nigerian patients are not literate in English \[[@pone.0221138.ref022]\]. Nigeria, as the most populous black African nation, is a multi-ethnic and multi-lingual country but with three major ethnic groups (Hausa, Igbo, and Yoruba) and with different languages. The Yoruba tribe makes up close to 40 million people \[[@pone.0221138.ref024]\], this should be among the largest ethnic groups of sub-Saharan Africa. Besides, other countries including the Benin Republic, Togo and Brazil speak the Yoruba language. \[[@pone.0221138.ref025],[@pone.0221138.ref026]\]. Therefore, the availability of ODI in the Yoruba language will improve the uptake of the tool among Yoruba speaking patients with LBP. This study aimed to cross-culturally adapt, test the convergent validity, small detectable change, factor structure, ceiling and floor effects and test-retest reliability of the ODI among patients with LBP.

Materials and methods {#sec006}
=====================

Ethical approval and informed consent {#sec007}
-------------------------------------

The Health Research and Ethics Committee of the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria gave ethical approval for this study (ERC/2015/12/05) (for a period between 10/12/2015 and 10/01/2016). The respondents also gave their written informed consents prior to participation in the study. Further, the respective heads of departments of the selected hospitals gave administrative permission to conduct the study.

Study design {#sec008}
------------

Cultural adaptation, test-retest and cross-sectional psychometric analyses.

Instruments {#sec009}
-----------

### The Oswestry disability questionnaire {#sec010}

The ODI questionnaire is a ten 6-point questionnaire. The first segment of the tool assesses the intensity of pain, while the remaining sections assess the disabling effect of pain on typical daily activities such as personal care, lifting, walking, sitting, standing, sleeping, sex life, social life, and traveling. Each item has scores ranging from 0 to 5, with the sum of scores of the 10 items expressed as a percentage of the maximum scores, varying from 0 (no disability) to 100 (maximum disability). Typically, it takes about five minutes to complete the questionnaire and less than one minute to compute scores \[[@pone.0221138.ref003]\].

### The Yoruba version of the Visual Analogue Scale (VAS) {#sec011}

The VAS represents the intensity dimension of pain by a 10 cm line with two anchors of "no pain" and "worst pain I ever felt" \[[@pone.0221138.ref027]\]. The VAS assesses pain intensity, has excellent psychometric properties, and has wide applicability in clinical and research settings \[[@pone.0221138.ref027]--[@pone.0221138.ref030]\].

Odole and Akinpelu \[[@pone.0221138.ref029]\] reported a moderate correlation between the English version and the translated Yoruba version of the VAS.

Cultural adaptation of the ODI to the Yoruba Language {#sec012}
-----------------------------------------------------

Using a five-step guideline proposed by Guillemin, Bombardier, and Beaton \[[@pone.0221138.ref021]\], the English version of the ODI questionnaire was translated into the Yoruba language. The translation process in sequential order comprised:

i.  Forward translation of the items and response choices of the English version of the ODI to the Yoruba language by two professionally qualified translators who are both native speakers of Yoruba language and bilingual in Yoruba and English languages. One translator had information about the concepts being examined in the questionnaire. This stage involved two forward translations referred to as T1 and T2.

ii. Synthesis: Synthesis: The two translators and the researcher (CEM) produced a synthesized version (T3) following a reconciliation meeting.

iii. Back translation: Back translation: Two independent qualified English translators translated the synthesized version (T3) back into the English language (BT1 and BT2). They individually identified inconsistencies in the words and concepts of the synthesized version.

iv. Expert committee review: An expert committee comprising three of the researchers (CEM, OEO, and, OEJ, physiotherapists by profession) and all four translators met to discuss issues of cultural adaptations and linguistic equivalence with the original English version of ODI. The meeting produced the final version of the Yoruba ODI (T4). The expert committee made some adaptations to the ODI while translating it from the original English version. Some adaptations were made to the ODI-Y while translating it from the original English version. Specifically, in section one (items 2 and 3), the Yoruba word *àfaradà* was used instead '*dédé*' (which means moderate) which should have been the most suitable transliteration equivalent. However, using '*dédé*' in the context will not make a meaningful sentence. In section three (Abala kéta), the word '*Gbígbé* had to be qualified in the ODI-Y, with '*Nnkan*' to become '*Nnkan gbígbé*' which means lifting. Also, item 5 in section three, was translated in the passive form, as a direct translation in the active cast may convey a different meaning, apart from that intended in the original translation. In section five (Abala Karùn-ún), item 1, the term 'favourite chair' was changed to 'comfortable chair' because the term favourite chair is not commonly used in this study context. In section seven (Abala Kéje), items 2, 3 and 4, the element of time translated as àsìkò was included to trade the sense of sleep duration missing in the literal equivalent of the translation in the Yoruba language.

v.  Pilot testing: Fifteen Yoruba speaking patients with LBP filled the pre-final version of the ODI (T4). The patients also undertook individualized cognitive debriefing. The cognitive debriefing was to explore the respondents' perception, understanding, interpretation of various terminologies used, and the formatting of the translated items of the T4. Analysis of the participants' interpretation of items evaluated whether or not the adapted version retained equivalence of the items in the English version. Reports were prepared at each stage to cover issues that were faced and how they were resolved.

Psychometric testing {#sec013}
--------------------

There is no consensus about the minimum required sample size for validation studies. However, no less 50 participants is considered adequate for construct validity, reliability, and ceiling/floor effects analyses \[[@pone.0221138.ref031]\]. Based on sample size ranges in previous studies on translation of the ODI, a sample range of between 30 and 126 \[[@pone.0221138.ref019], [@pone.0221138.ref020]\] was observed. Thus, a sample size estimate of 150 participants was considered adequate in this study. All the respondents in this study were recruited from three hospitals in the South-west zone of Nigeria namely: Obafemi Awolowo University Teaching Hospital complex Ile-Ife (OAUTHC), Wesley Guild Hospital, Ilesha, and University College Hospital, Ibadan. Eligibility for inclusion in the study was having a history of non-specific LBP of three months and longer, being literate in Yoruba languages, and having no cognitive impairment. The diagnostic criteria for non-specific LBP included the absence of serious pathology (red flags conditions such as fracture, malignancies or infection) and radicular syndrome. Volunteers with non-specific chronic LBP but with a systemic illness, rheumatologic diseases or other co-morbidity were excluded from the study. The ODI-Y and the VAS were administered on the participants on the same day. In addition to this, socio-demographic information and anthropometric measurements were also taken. Out of the 150 consenting patients with chronic LBP consulted for the cross-sectional study, only 136 (70 males and 66 females) returned their ODI-Y questionnaires validly completed. Eighty-six respondents (55.9±11.0 years; 54.7% female) completed the ODI-Y again after seven days of the first administration. The test-retest sample was a subset of the sample that took part in the validity assessment of the ODI and also consented to partake in the test-retest phase of the study.

Data analysis {#sec014}
-------------

Data were assessed for normality using visual (normal distribution curve and Q-Q plot) and statistical methods (Shapiro-Wilk's test and Skeweness/Kurtosis scores). Data were summarized using descriptive statistics of mean, standard deviation, percentages and median.

Validity: Construct validity describes the extent to which an outcome is able to measure a construct it was intended to measure. To our knowledge, there is no "gold standard" measure of the ODI and therefore it is not possible to assess criterion validity. However, construct validity of the ODI-Y was determined by correlating the ODI-Y scores with the Yoruba language VAS. The construct validity was assessed using the Spearman's correlation coefficients (data was not normally distributed), and was rated as weak (0--0.2), moderate (0.3--0.6), and strong (0.7--1.0) \[[@pone.0221138.ref032]\]. The choice of the VAS in the validity assessment of the ODI was informed by the established relationship between the two in the literature \[[@pone.0221138.ref033], [@pone.0221138.ref034]\].

Exploratory factor analysis (EFA), which shows the number of items of a scale that go together, was used to determine the factor structure of the ODI-Y \[[@pone.0221138.ref035]\]. Kaiser-Meyer- Olkin value, Bartlett's test of sphericity and correlation matrix table was used to check the suitability of the ODI-Y data prior to the conduction of principal component analysis (PCA). The authors set the minimum eigen value for factor retention to be ⩾1.0. Retained and excluded factors were also explored using parallel analysis. Promax (oblique) rotation, which assumes that factors can be related, was done with factor loadings less than 0.4 suppressed. Extraction was done using principal axis factoring. The number of factors and the interrelationships between the items loading in each factor were then compared with the factor structures of the previous ODI to find out whether there were differences owing to dissimilar population characteristics.

The reliability of the ODI-Y (an indication of how the instrument measures consistently over time) was determined using the Intra-Class Correlation (ICC). The absolute agreement, 2-way random-effects approach which assumes that errors in measurement could arise from either raters or participants) was used for the test-retest reliability of the ODI-Y. An ICC in the range of 0.4--0.75 was regarded as moderate, while values below and above this range were considered low and high respectively \[[@pone.0221138.ref036]\]. Reliability was also evaluated using the standard error of measurement (SEM) and minimal detectable change (MDC). Minimal detectable change is defined as the amount of change in a score that is required to distinguish a true performance change from a change due to chance \[[@pone.0221138.ref037]\]. The MDC was calculated using the standard error of measurement (which is based on the standard deviation of observed test scores for a given true test score). The standard error of measurement of the ODI-Y was calculated using the formula: $SEM = SD\sqrt{1 - R}$ \[[@pone.0221138.ref033]\]. Further, the MDC of the ODI-Y was calculated with the formula: *MDC* = 1.96×√2×*SEM* \[[@pone.0221138.ref037]\]. Bland-Altman analysis \[[@pone.0221138.ref038]\] was also used to visually assess heterodascity between test-retest measurements by plotting mean scores against difference in total scores. Cronbach alpha was used to test for the internal consistency of the ODI-Y respectively. A Cronbach's alpha not less 0.7 is recommended for outcome measures \[[@pone.0221138.ref039]\]. Potential ceiling and floor effects were considered present if \>15% of respondents achieved the lowest (10%) or highest possible total scores (100%) \[[@pone.0221138.ref031]\]. Data were analysed using SPSS (Statistical Package for Social Sciences) for Windows (Version 16.0. Chicago, SPSS Inc.) Alpha level was set as 0.05.

Results {#sec015}
=======

The age of the 131 participants ranged from 35--70 years. The mean age, weight, height and BMI of the respondents (51.5% females) was 50.7±10.6years, 75.0±11.2Kg, 1.67±0.04m, and 26.71±4.23Kg/m^2^ respectively. The general characteristics of the respondents by gender are presented in [Table 1](#pone.0221138.t001){ref-type="table"}. Shapiro-Wilk's normality test (p \< 0.05), as well as, the Q-Q plots observation, showed that the ODI-Y was not normally distributed.

10.1371/journal.pone.0221138.t001

###### General characteristics of the participants by gender (N = 136).

![](pone.0221138.t001){#pone.0221138.t001g}

  --------------------------------------------------------------
  Variables       Male\         Female\       t-cal    p-value
                  Mean ± SD     Mean ± SD              
  --------------- ------------- ------------- -------- ---------
  Age (years)     48.5 ± 10.7   52.7 ± 10.2   -2.328   0.021

  Weight (kg)     74.9 ± 10.9   75.1 ± 11.5   -0.083   0.834

  Height (m)      1.68 ± 0.04   1.68 ± 0.04   0.706    0.482

  BMI (Kg/m^2^)   26.6 ± 4.21   26.8 ± 4.28   -0.255   0.799
  --------------------------------------------------------------

SD: Standard deviation; BMI: body mass index

The Spearman's rank correlation coefficient for the convergent validity of the ODI-Y with the VAS was r = 0.30; p = 0.001. The 1-week test-retest reliability of the ODI-Y using ICC was 0.80 (95% CI 0.74--0.84). Further, the internal consistency of the ODI-Y was 0.81. The Item by Item Correlation between the Test-Retest of the ODI-Y and the Cronbach's Alpha if an item of the ODI-Y is deleted are presented in Tables [2](#pone.0221138.t002){ref-type="table"} and [3](#pone.0221138.t003){ref-type="table"} respectively. The SEM and MDC of the ODI-Y were 2.0 and 5.5. The mean difference between the test and retest scores as shown by Bland-Altman analysis was -0.26. Further, only 2 outliers affected the 95% limits of agreements.

10.1371/journal.pone.0221138.t002

###### Reliability of the Yoruba version of the ODI.

![](pone.0221138.t002){#pone.0221138.t002g}

  Global score of the ODI (α)   0.81
  ----------------------------- ----------------------------------
  Item                          Cronbach's alpha if Item Deleted
  1                             0.814
  2                             0.783
  3                             0.806
  4                             0.781
  5                             0.798
  6                             0.775
  7                             0.80
  8                             0.775
  9                             0.775
  10                            0.784

ODI: Oswestry disability index; α; Cronbach's alpha.

10.1371/journal.pone.0221138.t003

###### Test-retest of the Yoruba version of the ODI.

![](pone.0221138.t003){#pone.0221138.t003g}

                 ICC     95% CI
  -------------- ------- --------------
  Global score   0.80    0.74--0.84
  Item by item           
  1              0.876   0.80--0.92
  2              0.917   0.872--0.946
  3              0.971   0.955--0.981
  4              0.939   0.906--0.96
  5              0.969   0.952--0.98
  6              0.94    0.911--0.962
  7              0.893   0.833--0.931
  8              0.929   0.891--0.954
  9              0.900   0.846--0.935
  10             0.945   0.915--0.964

ODI: Oswestry disability index; ICC: intra-class correlation; CI: confidence interval

Principal component analysis (PCA) with Promax rotation was used to evaluate the factor structure of the ODI-Y. To determine that the data was suitable for factor analysis, indicators including the correlation matrix table (presence of many coefficients \> 0.3), Kaiser-Meyer- Olkin measure of sampling adequacy (0.74) and Bartlett's test of sphericity (*X*^2^ = 432.34, p \< 0.001) were considered; all of them indicated that PCA could proceed. Only factors with eigen value \>1 were considered to contribute significantly to explaining variance. Factors loading \> 0.3 were included in the model. Principal components extraction yielded a total of three factors which accounted for 61.56% of the total variance of the 10 factors. The first factor, with an eigenvalue of 3.9, consisted of items 2, 4, 6, 8, 9 and 10 accounting for 39.5% of the variance. The second factor, with an eigenvalue of 1.2, consisted of items 5 and 7 accounting for 12% of the variance. The third factor with an eigenvalue of 1.0 consisted of items 1 and 3 accounting for 10.1% of the variance. This is presented in [Table 4](#pone.0221138.t004){ref-type="table"}.

10.1371/journal.pone.0221138.t004

###### Principal component analysis of the Yoruba version of the ODI.

![](pone.0221138.t004){#pone.0221138.t004g}

  Item                           Factor 1                                          Factor 2                                          Factor 3                                          Communality
  ------------------------------ ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- -------------
  1\. Pain                       0.118                                             -0.281                                            **0.813**[^a^](#t004fn001){ref-type="table-fn"}   0.703
  2\. Personal care              **0.657**[^a^](#t004fn001){ref-type="table-fn"}   0.017                                             0.088                                             0.484
  3\. Lifting                    -0.095                                            0.383                                             **0.741**[^a^](#t004fn001){ref-type="table-fn"}   0.735
  4\. Walking                    **0.643**[^a^](#t004fn001){ref-type="table-fn"}   0.150                                             0.006                                             0.516
  5\. Sitting                    0.113                                             **0.608**[^a^](#t004fn001){ref-type="table-fn"}   0.090                                             0.472
  6\. Standing                   **0.793**[^a^](#t004fn001){ref-type="table-fn"}   -0.014                                            0.026                                             0.633
  7\. Sleeping                   0.021                                             **0.883**[^a^](#t004fn001){ref-type="table-fn"}   -0.141                                            0.769
  8\. Sex                        **0.715**[^a^](#t004fn001){ref-type="table-fn"}   -0.074                                            0.200                                             0.593
  9\. Social life                **0.668**[^a^](#t004fn001){ref-type="table-fn"}   0.065                                             0.126                                             0.554
  10\. Travelling                **0.864**[^a^](#t004fn001){ref-type="table-fn"}   0.023                                             -0.302                                            0.698
  Eigenvalue                     3.95                                              1.20                                              1.0                                               
  \% of the variance explained   39.47                                             12.0                                              10.0                                              

^**a**^Principal component coefficient ≥ 0.4

ODI: Oswestry disability index

The ODI-Y had no ceiling or floor effect as no respondent had the maximum possible score and only 2.2% of respondents had the minimum possible score.

Discussion {#sec016}
==========

To the best of our knowledge, this is the first study that cross-culturally adapted the ODI-Y and determined its psychometric properties. The respondents in this study were patients with chronic LBP with whom maladaptive illness beliefs and disability are common \[[@pone.0221138.ref040], [@pone.0221138.ref041]\]. Disability associated with chronic LBP is an intricate and multidimensional phenomenon \[[@pone.0221138.ref042]\] that further perpetuates chronicity of LBP \[[@pone.0221138.ref043], [@pone.0221138.ref044]\]. Thus, disability resulting from LBP is associated with difficulty in performing almost all basic and instrumental activities of daily living \[[@pone.0221138.ref040], [@pone.0221138.ref045]\].

To attain comprehensive multidimensional assessment of the burden, as well as, intervention outcomes, tools such as the RMDQ and ODI have enjoyed widespread application in clinical and research settings \[[@pone.0221138.ref046], [@pone.0221138.ref047]\], owing to the good to excellent psychometric properties of the original versions, variants and translations of these tools \[[@pone.0221138.ref048], [@pone.0221138.ref049]\].

The finding of the current study on the convergent validity of ODI-Y with VAS shows a weak but significant correlation. This finding is consistent with previous results on ODI translations, showing significant correlation between translated versions of ODI and pain tools with correlation co-efficient values ranging weak to high. For example, the correlation co-efficient for Norwegian (0.52) \[[@pone.0221138.ref010]\], Korean (0.42) \[[@pone.0221138.ref013]\], Swiss-German (0.78) \[[@pone.0221138.ref015]\], Iranian (0.54) \[[@pone.0221138.ref017]\] and Brazilian-Portuguese (0.66) \[[@pone.0221138.ref018]\] versions of the ODI, showed weak to high correlation with pain intensity. The positive but weak correlation between ODI-Y and pain intensity observed in this study may suggest that the new tool is valid for measuring the presence functional disability rather than severity of pain.

The test-retest of the ODI-Y within 1-week interval showed a high correlation based on the ICC value. High ICC coefficient obtained in this study conforms with the recommendation of an ICC of 0.75 or more, considered in many studies as reliable \[[@pone.0221138.ref008]\]. The narrow 95% CI obtained for the ICCs in this study confirms that the ODI-Y can yield reliable results when administered on multiple occasions. Thus, the results on test-retest reliability obtained in this study are comparable with those reported in the Norwegian \[[@pone.0221138.ref010]\], Korean \[[@pone.0221138.ref013]\], and Brazilian-Portuguese \[[@pone.0221138.ref018]\] versions, where an ICC range of between 0.7 and 0.99 has been observed for intervals ranging from 2 days to 4 weeks \[[@pone.0221138.ref050]\].

Another finding of this study indicate that SEM and MDC of the ODI-Y were 2.0 and 5.5, while the by Bland-Altman analysis showed a mean difference of -0.26 between the test and retest scores. The estimated SEM (2.0) of the ODI-Y resulted in a MCD~95%~ of 5.5. The MDC~95%~ found in our study was similar to that reported in the Croatian version of the ODI (6.0) \[[@pone.0221138.ref050]\]. The MDC of the ODI-Y was lower than that of the Polish (MDC = 10) \[[@pone.0221138.ref051]\]; German (9.0) \[[@pone.0221138.ref015]\]; Hungarian (MDC = 11) \[[@pone.0221138.ref052]\] and Chinese (12.8) \[[@pone.0221138.ref053]\] translations of the ODI. An MDC of 5.5 found in our study implies that below 5.5, the measurement error of the ODI-Y is indistinguishable. That only 2 outliers affected the 95% limits of agreements during the Bland-Altman analysis indicates a very strong agreement between the test and retest scores and minimal within-subject variations. The Bland-Altman analysis accounts for the shortcoming of the ICC which might indicate strong correlations between two measurements with minimal agreement \[[@pone.0221138.ref054]\]. The findings of this study show that the ODI-Y had a high internal consistency. A higher internal consistency \> 0.95 would have indicated a redundancy in the questionnaire items. The internal consistencies of most of the ODI translations \[[@pone.0221138.ref049], [@pone.0221138.ref050], [@pone.0221138.ref055]\] fall within this band.

Principal component analysis of the ODI-Y revealed a three-factor structure accounting for 61.56% of the variance. The first factor (everyday activities) includes personal care, walking, sitting, standing, sex life, social life, and travelling, second factor (sedentary activities) includes sleeping and sitting while the third factor (pain/lifting) includes pain and lifting. Most factor analyses of the language translations of the ODI yielded one factor \[[@pone.0221138.ref005], [@pone.0221138.ref015], [@pone.0221138.ref056], [@pone.0221138.ref057], [@pone.0221138.ref058]\] or two-factor structures \[[@pone.0221138.ref050], [@pone.0221138.ref059], [@pone.0221138.ref060], [@pone.0221138.ref061]\]. Such factors reported in previous two-factor models include social/ recreational activities and non-recreational activities \[[@pone.0221138.ref050]\], dynamic and static activities \[[@pone.0221138.ref059], [@pone.0221138.ref062]\], pain-related activity, and pain intensity and pain-related participation \[[@pone.0221138.ref055]\]. Gabel and colleagues \[[@pone.0221138.ref062]\] conducted a PCA of the ODI in a large sample of patients with LBP derived from the international Spine Tango registry of EUROSPINE. Their analysis yielded a single-factor model which was confirmed by the CFA. They further conducted a CFA on the literature-recommended two-factor model of the ODI; this yielded indicators which were not within the ranges of acceptable fit. Based on the evidence from the study by Gabel et al \[[@pone.0221138.ref062]\], that none of the previous two-factor models have similar factor loading, and the results from our study, it is recommended that a global score of the ODI be used in research and the clinical settings. The unidimensionality of the ODI, however, remains debatable. Larger sample size studies are thus needed to provide answers to the dimensionality of the ODI. Furthermore, the findings of this study indicate that the ODI-Y had no floor or ceiling effects. Floor and ceiling effect refers to the percentage of patients scoring maximal or minimal scores. It is recommended that questionnaires with more than 15% of the respondents scoring either the maximal or minimal scores should not be used. Thus, application of ODI-Y seems not to be limited by any concern of floor or ceiling effects. In sum, the ODI-Y showed acceptable internal consistency, test-retest reliability, convergent validity, a three-factor structure, and no floor or ceiling effects. This study is not without potential limitations. Firstly, generalizability of the findings to other population other than those with chronic LBP should be treated with caution. Further, a not large enough sample size renders a Rasch analysis of the ODI-Y not meaningful, thus losing vital results that bother on unidimensionality, appropriateness of response categories for each item (category function) and equivalence of items on meaning to different respondents (differential item functioning) that may have been gotten from the analysis. Overall, the ODI-Y is recommended for assessing patients with chronic LBP among the Yoruba population.

Conclusion {#sec017}
==========

The Yoruba version of the ODI questionnaire is valid and reliable, with adequate psychometric properties, and it can be used in Yoruba speaking patients with chronic LBP. The psychometric properties of the ODI-Y are comparable with the original English and other translations of the ODI.

Supporting information {#sec018}
======================

###### The ODI validity data (n = 136).

(XLSX)

###### 

Click here for additional data file.

###### The ODI-Yoruba test-retest reliability data.

(XLSX)

###### 

Click here for additional data file.

###### Ìgbéléwòn Bèbèré Èyìn Dídùn ti Oswestry (The Yoruba Oswestry Disability Index).

(DOCX)

###### 

Click here for additional data file.
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2.  Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <http://journals.plos.org/plosone/s/supporting-information>.

3\. Please carefully proofread your manuscript for typographical errors. For example, on page 8 "However, no less 50 participants be considered adequate..." should be "However, no less than 50 participants is considered adequate..."

4\. Please state in your methods section the participant recruitment date.

5\. Please state the participants age range (in addition to their mean age).

6\. Please amend your current ethics statement and methods section to address the following concerns:   a) Did participants provide their written or verbal informed consent to participate in this study?  b) If consent was verbal, please explain:  i) Why was written consent not obtained?   ii) How did you record/document participant consent?  iii) Did the ethics committees/IRBs approve this consent procedure?

7\. Please amend the manuscript submission data (via Edit Submission) to include author Ajibola Babatunde Oladiran.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Cross-cultural adaptation and psychometric evaluation of the Yoruba version of

Oswestry disability index

Thank you for the opportunity to review the manuscript. I reviewed this manuscript carefully with a great interest. I respectfully provided my comments below

Methods

1: In methods section no description for validation( face, content, construct (EFA and CFA) and convergent) are provided. Please give more details about that.

2: Where did the 280150 samples for EFA and CFA come from? Did the authors do the power analysis for the sample sizes?

3: The choice of PCA to evaluate the factor structure of the ODI-Y appears somewhat rudimentary given the increasingly sophisticated statistically methods that have been used to evaluate the scale since the publication of the original article. It would be good to know why the author has chosen to use PCA rather than using structural equation models which have become much more commonly used to test the psychometric properties of scales.

4: What rotation model of EFA was used?

5: .Say more about the sample of 86 who completed the questionnaire twice. Who were they?

Data Analysis

1:Please report first the result validity next reliability

2 The values for RMSEA is higher and not adequate. Its cut off value is 0.08 according to Bentler & Hu

3: GFI= 0.87; AGFI=0.85: These values should at least be higher than 0.90. The model has inadequate model of fit

4: Lastly, factors should be retained using Parallel Analysis. Scree plot and Eigen values are traditional methods

The discussion part of this paper is not good. It would be better if you could write this part focusing on the results from the study

Reviewer \#2: It seems that the translation and adaptation steps as well as the validity and reliability of the questionnaire have been done to an acceptable level. However, there are problems that should be addressed by the authors:

\- In the first principal component analysis, three factors with a variance accounting for 62% were obtained. What was the authors\' justification for the second principal component analysis with two factors and less variance coverage than the previous one (about 51%)? (lines: 247-283\]

\- Principal component analysis for construct validity was not performed in a single-factor model but was performed in confirmatory factor analysis; What is the reason for this.

\- The amount reported to cover the variance of the second principal component analysis in the abstract (51.7%) does not match with main text (51.47%).

\- Report the factor loading of all items in the exploratory factor analysis output table

\- The population under study in exploratory and confirmatory factor analysis should be distinct. However, none of the model versions had the optimal fit indices in factor analysis. Therefore, it may be advisable not to perform a factor analysis in this article and perform it in a distinct population.

\- The authors in the results section in the abstract have stated that: \" the ODI-Y yielded a two-factor structure which accounted for 51.7% of the 54 variance but showed poor fit.\"

But in the discussion section they stated that: \"the ODI was adapted into the Yoruba language and proved to have a 58 good factor structure and psychometric properties that replicated the results of other 59 obtainable versions.\" Don\'t these two terms contradict each other?

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Razieh Bandari

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]
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17 Dec 2019

Journal Requirements as requested by academic editor:

1\. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

A: We have addressed this to the best of our ability. Thank you very much.

2\. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <http://journals.plos.org/plosone/s/supporting-information>.

A: We included captions for our supporting information and updated all in-text citations to match.

3\. Please carefully proofread your manuscript for typographical errors. For example, on page 8 "However, no less 50 participants be considered adequate..." should be "However, no less than 50 participants is considered adequate..."

A: We have proofread our manuscript and corrected all the typographical errors. Thank you.

4\. Please state in your methods section the participant recruitment date

.A: The participant recruitment date (10/12/2015 and 10/01/2016) has been included in the methods section) (Page 5, line 109)

5\. Please state the participants' age range (in addition to their mean age).

A: The age range of the participants (35-70 years) has been included (Page 11, line 250).

6\. Please amend your current ethics statement and methods section to address the following concerns: a) Did participants provide their written or verbal informed consent to participate in this study? b) If consent was verbal, please explain: i) Why was written consent not obtained? ii) How did you record/document participant consent? iii) Did the ethics committees/IRBs approve this consent procedure?

A: Thank you very much for highlighting this omission in our manuscript. The participants provided their written informed consent. The consent procedure was approved by the ethics committee/IRB (Page 5, line 110).

7\. Please amend the manuscript submission data (via Edit Submission) to include author Ajibola Babatunde Oladiran.

A: This has been done. Thank you very much for pointing this out.

\[Note: HTML markup is below. Please do not edit.\]

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

Reviewers\' comments:

Reviewer\'s Responses to Questions

Comments to the Author

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Partly

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: No

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Cross-cultural adaptation and psychometric evaluation of the Yoruba version of Oswestry disability index

Thank you for the opportunity to review the manuscript. I reviewed this manuscript carefully with a great interest. I respectfully provided my comments below

Methods

1: In methods section no description for validation (face, content, construct (EFA and CFA) and convergent) are provided. Please give more details about that.

A: Thank you very much for pointing our attention to this; we have included more details about the EFA and convergent validity. We have had to remove the CFA following the suggestion of the second reviewer (Page 9, Line 205- page 10 Line 224).

2: Where did the 280150 samples for EFA and CFA come from? Did the authors do the power analysis for the sample sizes?

A: We didn't do a power analysis. However, we adopted a minimum sample size for the EFA.

3: The choice of PCA to evaluate the factor structure of the ODI-Y appears somewhat rudimentary given the increasingly sophisticated statistically methods that have been used to evaluate the scale since the publication of the original article. It would be good to know why the author has chosen to use PCA rather than using structural equation models which have become much more commonly used to test the psychometric properties of scales.

A: Thank you very much for enlightening us about the superiority of structural equation modelling over PCA. Our sample was less than the 200 minimum sample size for the CFA and SEM. We had to use the PCA which our sample was adequate for. We hope to explore this suggestion subsequently.

4: What rotation model of EFA was used?

A: We have included this in the manuscript (Promax rotation): Page 10, line 220)

5: .Say more about the sample of 86 who completed the questionnaire twice. Who were they?

A: We have included the mean age and gender of participants who took part in the retest phase "(55.9±11.0 years; 54.7% female)" (Page 9, line 195).

Data Analysis

1:Please report first the result validity next reliability

A: This had been done, thank you ( Page 12, lines 260-267)

2 The values for RMSEA is higher and not adequate. Its cut off value is 0.08 according to Bentler & Hu

3: GFI= 0.87; AGFI=0.85: These values should at least be higher than 0.90. The model has inadequate model of fit

A: We have removed the CFA analysis from the study due to the inadequacy of our sample size and the suggestion of the second reviewer.

4: Lastly, factors should be retained using Parallel Analysis. Scree plot and Eigen values are traditional methods

A: This had been done thank you very much for the great inputs to our manuscript (Page 10, line 219).

The discussion part of this paper is not good. It would be better if you could write this part focusing on the results from the study

A: We have overhauled the discussion section as recommended. Thank you.

Reviewer \#2: It seems that the translation and adaptation steps as well as the validity and reliability of the questionnaire have been done to an acceptable level. However, there are problems that should be addressed by the authors:

\- In the first principal component analysis, three factors with a variance accounting for 62% were obtained. What was the authors\' justification for the second principal component analysis with two factors and less variance coverage than the previous one (about 51%)? (lines: 247-283\]

A: thank you very much for this important observation. We wanted a structure that could be explainable looking at the items loading in them. However we have decided to stick to the initial PCA analysis as it has more variance coverage and the factors can also be explained.

\- Principal component analysis for construct validity was not performed in a single-factor model but was performed in confirmatory factor analysis; What is the reason for this.

A: Thank you very much. Events have overridden this as we have removed the CFA in its entirety from the study.

\- The amount reported to cover the variance of the second principal component analysis in the abstract (51.7%) does not match with main text (51.47%).

A: Thank you very much for noting this error. We have however expunged the second rotation and stuck to the first.

\- Report the factor loading of all items in the exploratory factor analysis output table

A: We have reported the factor loadings of all items in the exploratory factor analysis output table (Page 14, 291).

\- The population under study in exploratory and confirmatory factor analysis should be distinct. However, none of the model versions had the optimal fit indices in factor analysis. Therefore, it may be advisable not to perform a factor analysis in this article and perform it in a distinct population.

A: thank you very much for the advice, this partly informed our removal of the CFA from our analysis

\- The authors in the results section in the abstract have stated that: \" the ODI-Y yielded a two-factor structure which accounted for 51.7% of the 54 variance but showed poor fit.\"

But in the discussion section they stated that: \"the ODI was adapted into the Yoruba language and proved to have a 58 good factor structure and psychometric properties that replicated the results of other 59 obtainable versions.\" Don\'t these two terms contradict each other?

A: Thank you very much. This was an error and we have adjusted the write up only to highlight the psychometric properties what were explored in the study.

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
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